Beroni Logo @ Dec 2019.png
Beroni Group Announced the Latest Clinical Study of its SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method)
31 août 2021 08h30 HE | Beroni Group Limited
NEW YORK and SYDNEY, Australia, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, announced the latest clinical...
researchdrivelogo.jpg
Increasing Cases of Coronavirus Infection around the World to Propel the Growth of Global COVID-19 Diagnostics Market – Exclusive Report [410 Pages] By Research Dive
18 août 2021 09h04 HE | Research Dive
New York, USA, Aug. 18, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global covid-19 diagnostics market is expected to generate a revenue of $65,750.1 million by...
ibn-iw-globe-2.png
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp.
12 mars 2021 08h17 HE | InvestorBrandNetwork (IBN)
LOS ANGELES, March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
Logo.png
GTX Corp Adds Rapid Diagnostic Test Kits for the SARS-COV-2 (COVID-19) Antigen
18 févr. 2021 08h35 HE | GTX Corp
LOS ANGELES, CALIFORNIA, Feb. 18, 2021 (GLOBE NEWSWIRE) -- GTX Corp (OTC: GTXO) (“GTX” or the “Company”), a pioneer in the field of wearable GPS human and asset tracking systems and a supplier of...
Achiko Logo cropped.jpg
Achiko Establishes Joint Venture with PT Indonesia Farma Medis for Production and Distribution of its Test Platform for Covid-19 in Indonesia
12 févr. 2021 07h30 HE | Achiko AG
Achiko Signs Agreement with PT Indonesia Farma Medis to Establish a New Joint Venture, including a Contract with PT Mitra Asa Pratama and a Memorandum of Understanding with PT Pharos Indonesia,...
Achiko Logo cropped.jpg
Achiko Strengthens Leadership Team with New President and New SVP Commercialization
11 janv. 2021 07h30 HE | Achiko AG
Appoints New President, Biotechnology Research Scientist and Entrepreneur Dr. Morris S. Berrie Appoints New SVP Commercialization, Business Leader in Life Science Richard Lingard New Senior Leadership...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Announces the Submission of a Marketing Authorization Application to COFEPRIS (Mexico) for COVI-STIX™ Rapid Detection Test of SARS-CoV-2 Viral Antigen
30 déc. 2020 12h48 HE | Sorrento Therapeutics, Inc.
SAN DIEGO, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that a Marketing Authorization Application has been submitted by its agents in...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Receives Licensure From the State of California for Clinical Testing Laboratory (CLIA) Allowing for Clinical Sample Testing
08 déc. 2020 20h06 HE | Sorrento Therapeutics, Inc.
Sorrento receives Clinical Laboratory Improvement Amendments (CLIA) license from the State of California for clinical sample testingSorrento intends to initially offer three diagnostic tests for...
Achiko Logo cropped.jpg
Achiko Secures Convertible Loan Facility with Yorkville Advisors of USD $2.5 Million, with a Provisional Extension of Up to USD $9.5 Million
26 nov. 2020 07h00 HE | Achiko AG
ZURICH, Switzerland, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Achiko AG (SWX:ACHI, ISIN CH0522213468) announces the completion of a convertible loan facility with US based fund manager Yorkville Advisors...
Achiko Logo cropped.jpg
Achiko AG Appoints Toolbox Medical Innovations and NDA Group and Expands Advisory Board
02 nov. 2020 08h52 HE | Achiko AG
Encouraging Initial Results to Date in Field Validation TrialsToolbox Medical Innovations Engaged for the Design of the Commercial Test KitNDA Group Engaged to Assist in Progress Towards CE...